Analyze Diet
Infection and immunity2004; 72(6); 3228-3236; doi: 10.1128/IAI.72.6.3228-3236.2004

Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses.

Abstract: Horses that have undergone infection caused by Streptococcus equi subspecies equi (strangles) were found to have significantly increased serum antibody titers against three previously characterized proteins, FNZ (cell surface-bound fibronectin binding protein), SFS (secreted fibronectin binding protein), and EAG (alpha2-macroglobulin, albumin, and immunoglobulin G [IgG] binding protein) from S. equi. To assess the protective efficacy of vaccination with these three proteins, a mouse model of equine strangles was utilized. Parts of the three recombinant proteins were used to immunize mice, either subcutaneously or intranasally, prior to nasal challenge with S. equi subsp. equi. The adjuvant used was EtxB, a recombinant form of the B subunit of Escherichia coli heat-labile enterotoxin. It was shown that nasal colonization of S. equi subsp. equi and weight loss due to infection were significantly reduced after vaccination compared with a mock-vaccinated control group. This effect was more pronounced after intranasal vaccination than after subcutaneous vaccination; nearly complete eradication of nasal colonization was obtained after intranasal vaccination (P < 0.001). When the same antigens were administered both intranasally and subcutaneously to healthy horses, significant mucosal IgA and serum IgG antibody responses against FNZ and EAG were obtained. The antibody response was enhanced when EtxB was used as an adjuvant. No adverse effects of the antigens or EtxB were observed. Thus, FNZ and EAG in conjunction with EtxB are promising candidates for an efficacious and safe vaccine against strangles.
Publication Date: 2004-05-25 PubMed ID: 15155624PubMed Central: PMC415648DOI: 10.1128/IAI.72.6.3228-3236.2004Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper investigates the protective properties of three proteins generated by Streptococcus equi in combatting strangles infection in horses. The study utilized a mouse model and demonstrated that these proteins, when used as a vaccine, significantly reduced the severity of the infection.

Overview of the Research

  • The research found that horses infected by Streptococcus equi, the bacterium that causes strangles, had greatly increased antibody titers against three specific proteins produced by the bacterium, FNZ, SFS, and EAG.
  • These proteins were characterized further and were used to formulate a vaccine to enhance the body’s immune response against the strangles bacterium.

Experimental Design

  • The researchers used a mouse model to test the efficacy of their vaccine, which included components of these three proteins.
  • Mice were immunized with the vaccine and then nasal challenge was used to introduce the Streptococcus equi bacterium.
  • The EtxB adjuvant, a component of Escherichia coli toxin, was used to increase the effectiveness of the vaccine.

Results of the Research

  • The study found that immunized mice showed a significant reduction in nasal colonization by the bacterium and resultant weight loss, compared to a control group that was not vaccinated.
  • Intranasal vaccination was more effective than subcutaneous vaccination, almost completely eliminating nasal colonization of the bacterium.
  • When the same vaccine was administered to healthy horses, it triggered significant immune response in the form of mucosal IgA and serum IgG antibodies.
  • This immune response was stronger when the EtxB adjuvant was used in conjunction with the vaccine.
  • No adverse effects were observed from the antigens or the EtxB adjuvant.

Conclusion of the Study

  • The study concludes that these proteins, especially FNZ and EAG, used in conjunction with the EtxB adjuvant, are viable candidates for creating an effective and safe vaccine against strangles.

Cite This Article

APA
Flock M, Jacobsson K, Frykberg L, Hirst TR, Franklin A, Guss B, Flock JI. (2004). Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses. Infect Immun, 72(6), 3228-3236. https://doi.org/10.1128/IAI.72.6.3228-3236.2004

Publication

ISSN: 0019-9567
NlmUniqueID: 0246127
Country: United States
Language: English
Volume: 72
Issue: 6
Pages: 3228-3236

Researcher Affiliations

Flock, Margareta
  • Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Jacobsson, Karin
    Frykberg, Lars
      Hirst, Timothy R
        Franklin, Anders
          Guss, Bengt
            Flock, Jan-Ingmar

              MeSH Terms

              • Adhesins, Bacterial
              • Animals
              • Antibodies, Bacterial / blood
              • Bacterial Proteins / genetics
              • Bacterial Proteins / immunology
              • Bacterial Proteins / metabolism
              • Carrier Proteins
              • Horse Diseases / immunology
              • Horse Diseases / prevention & control
              • Horses
              • Membrane Glycoproteins
              • Mice
              • Recombinant Proteins / genetics
              • Recombinant Proteins / immunology
              • Recombinant Proteins / metabolism
              • Streptococcal Infections / prevention & control
              • Streptococcal Infections / veterinary
              • Streptococcal Vaccines / administration & dosage
              • Streptococcal Vaccines / genetics
              • Streptococcal Vaccines / immunology
              • Streptococcus equi / genetics
              • Streptococcus equi / immunology
              • Vaccination

              References

              This article includes 25 references
              1. Chanter N. Bacterial infections including mycoplasmas. In P. Lekeux (ed.), Equine respiratory diseases. International Veterinary Information Services, Ithaca, N.Y..
              2. Chanter N, Smith KC, Mumford JA. Equine strangles modelled in mice.. Vet Microbiol 1995 Feb;43(2-3):209-18.
                pubmed: 7740759doi: 10.1016/0378-1135(94)00090-jgoogle scholar: lookup
              3. Hamlen HJ, Timoney JF, Bell RJ. Epidemiologic and immunologic characteristics of Streptococcus equi infection in foals.. J Am Vet Med Assoc 1994 Mar 1;204(5):768-75.
                pubmed: 8175473
              4. Harrington DJ, Sutcliffe IC, Chanter N. The molecular basis of Streptococcus equi infection and disease.. Microbes Infect 2002 Apr;4(4):501-10.
                pubmed: 11932201doi: 10.1016/s1286-4579(02)01565-4google scholar: lookup
              5. Jacobs AA, Goovaerts D, Nuijten PJ, Theelen RP, Hartford OM, Foster TJ. Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi.. Vet Rec 2000 Nov 11;147(20):563-7.
                pubmed: 11104039doi: 10.1136/vr.147.20.563google scholar: lookup
              6. Jacobsson K, Jonsson H, Lindmark H, Guss B, Lindberg M, Frykberg L. Shot-gun phage display mapping of two streptococcal cell-surface proteins.. Microbiol Res 1997 Jul;152(2):121-8.
                pubmed: 9265766doi: 10.1016/s0944-5013(97)80002-xgoogle scholar: lookup
              7. Jonsson H, Lindmark H, Guss B. A protein G-related cell surface protein in Streptococcus zooepidemicus.. Infect Immun 1995 Aug;63(8):2968-75.
              8. Jorm LR. Strangles in horse studs: incidence, risk factors and effect of vaccination.. Aust Vet J 1990 Dec;67(12):436-9.
              9. Kihlberg BM, Collin M, Olsén A, Björck L. Protein H, an antiphagocytic surface protein in Streptococcus pyogenes.. Infect Immun 1999 Apr;67(4):1708-14.
              10. Lindmark H, Guss B. SFS, a novel fibronectin-binding protein from Streptococcus equi, inhibits the binding between fibronectin and collagen.. Infect Immun 1999 May;67(5):2383-8.
              11. Lindmark H, Jacobsson K, Frykberg L, Guss B. Fibronectin-binding protein of Streptococcus equi subsp. zooepidemicus.. Infect Immun 1996 Oct;64(10):3993-9.
              12. Lindmark H, Jonsson P, Engvall E, Guss B. Pulsed-field gel electrophoresis and distribution of the genes zag and fnz in isolates of Streptococcus equi.. Res Vet Sci 1999 Apr;66(2):93-9.
                pubmed: 10208886doi: 10.1053/rvsc.1998.0250google scholar: lookup
              13. Lindmark H, Nilsson M, Guss B. Comparison of the fibronectin-binding protein FNE from Streptococcus equi subspecies equi with FNZ from S. equi subspecies zooepidemicus reveals a major and conserved difference.. Infect Immun 2001 May;69(5):3159-63.
              14. Lunn DP, Holmes MA, Antczak DF, Agerwal N, Baker J, Bendali-Ahcene S, Blanchard-Channell M, Byrne KM, Cannizzo K, Davis W, Hamilton MJ, Hannant D, Kondo T, Kydd JH, Monier MC, Moore PF, O'Neil T, Schram BR, Sheoran A, Stott JL, Sugiura T, Vagnoni KE. Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995.. Vet Immunol Immunopathol 1998 Mar 31;62(2):101-43.
                pubmed: 9638857doi: 10.1016/s0165-2427(97)00160-8google scholar: lookup
              15. Molinari G, Rohde M, Guzmán CA, Chhatwal GS. Two distinct pathways for the invasion of Streptococcus pyogenes in non-phagocytic cells.. Cell Microbiol 2000 Apr;2(2):145-54.
              16. Nally JE, Artiushin S, Sheoran AS, Burns PJ, Simon B, Gilley RM, Gibson J, Sullivan S, Timoney JF. Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system.. Vaccine 2000 Oct 15;19(4-5):492-7.
                pubmed: 11027813doi: 10.1016/s0264-410x(00)00187-0google scholar: lookup
              17. Newton JR, Wood JL, Dunn KA, DeBrauwere MN, Chanter N. Naturally occurring persistent and asymptomatic infection of the guttural pouches of horses with Streptococcus equi.. Vet Rec 1997 Jan 25;140(4):84-90.
                pubmed: 9032908doi: 10.1136/vr.140.4.84google scholar: lookup
              18. Richards CM, Aman AT, Hirst TR, Hill TJ, Williams NA. Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant.. J Virol 2001 Feb;75(4):1664-71.
              19. Schalén C, Truedsson L, Christensen KK, Christensen P. Blocking of antibody complement-dependent effector functions by streptococcal IgG Fc-receptor and staphylococcal protein A.. Acta Pathol Microbiol Immunol Scand B 1985 Dec;93(6):395-400.
              20. Sheoran AS, Artiushin S, Timoney JF. Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin.. Vaccine 2002 Feb 22;20(11-12):1653-9.
                pubmed: 11858875doi: 10.1016/s0264-410x(01)00488-1google scholar: lookup
              21. Sheoran AS, Sponseller BT, Holmes MA, Timoney JF. Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses.. Vet Immunol Immunopathol 1997 Nov;59(3-4):239-51.
                pubmed: 9477475doi: 10.1016/s0165-2427(97)00074-3google scholar: lookup
              22. Takao SI, Kiyotani K, Sakaguchi T, Fujii Y, Seno M, Yoshida T. Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses.. J Virol 1997 Jan;71(1):832-8.
                pmc: PMC191127pubmed: 8985426doi: 10.1128/jvi.71.1.832-838.1997google scholar: lookup
              23. Timoney JF, Eggers D. Serum bactericidal responses to Streptococcus equi of horses following infection or vaccination.. Equine Vet J 1985 Jul;17(4):306-10.
              24. Walker JA, Timoney JF. Construction of a stable non-mucoid deletion mutant of the Streptococcus equi Pinnacle vaccine strain.. Vet Microbiol 2002 Nov 6;89(4):311-21.
                pubmed: 12383640doi: 10.1016/s0378-1135(02)00205-5google scholar: lookup
              25. Wood JL, Dunn K, Chanter N, de Brauwere N. Persistent infection with Streptococcus equi and the epidemiology of strangles.. Vet Rec 1993 Oct 9;133(15):375.
                pubmed: 8256427doi: 10.1136/vr.133.15.375-agoogle scholar: lookup

              Citations

              This article has been cited 7 times.
              1. Rönnberg E, Calounova G, Guss B, Lundequist A, Pejler G. Granzyme D is a novel murine mast cell protease that is highly induced by multiple pathways of mast cell activation.. Infect Immun 2013 Jun;81(6):2085-94.
                doi: 10.1128/IAI.00290-13pubmed: 23529614google scholar: lookup
              2. Ge X, Kitten T, Munro CL, Conrad DH, Xu P. Pooled protein immunization for identification of cell surface antigens in Streptococcus sanguinis.. PLoS One 2010 Jul 26;5(7):e11666.
                doi: 10.1371/journal.pone.0011666pubmed: 20668678google scholar: lookup
              3. Rönnberg E, Guss B, Pejler G. Infection of mast cells with live streptococci causes a toll-like receptor 2- and cell-cell contact-dependent cytokine and chemokine response.. Infect Immun 2010 Feb;78(2):854-64.
                doi: 10.1128/IAI.01004-09pubmed: 19933827google scholar: lookup
              4. Guss B, Flock M, Frykberg L, Waller AS, Robinson C, Smith KC, Flock JI. Getting to grips with strangles: an effective multi-component recombinant vaccine for the protection of horses from Streptococcus equi infection.. PLoS Pathog 2009 Sep;5(9):e1000584.
                doi: 10.1371/journal.ppat.1000584pubmed: 19763180google scholar: lookup
              5. Lewis MJ, Meehan M, Owen P, Woof JM. A common theme in interaction of bacterial immunoglobulin-binding proteins with immunoglobulins illustrated in the equine system.. J Biol Chem 2008 Jun 20;283(25):17615-23.
                doi: 10.1074/jbc.M709844200pubmed: 18411272google scholar: lookup
              6. Hamilton A, Robinson C, Sutcliffe IC, Slater J, Maskell DJ, Davis-Poynter N, Smith K, Waller A, Harrington DJ. Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation.. Infect Immun 2006 Dec;74(12):6907-19.
                doi: 10.1128/IAI.01116-06pubmed: 17015455google scholar: lookup
              7. Lannergård J, Flock M, Johansson S, Flock JI, Guss B. Studies of fibronectin-binding proteins of Streptococcus equi.. Infect Immun 2005 Nov;73(11):7243-51.